SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-069963
Filing Date
2020-06-05
Accepted
2020-06-04 21:38:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 tm2021693-1_s3.htm S-3 514624
2 EXHIBIT 4.5 tm2021693d2_ex4-5.htm EX-4.5 567340
3 EXHIBIT 23.1 tm2021693d1_ex23-1.htm EX-23.1 3175
4 GRAPHIC lg_appliedtherapeutics-4c.jpg GRAPHIC 220864
  Complete submission text file 0001104659-20-069963.txt   1386258
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238948 | Film No.: 20944350
SIC: 2834 Pharmaceutical Preparations